Search Results - "Terakura, S"

Refine Results
  1. 1

    Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation by Kanda, J, Morishima, Y, Terakura, S, Wake, A, Uchida, N, Takahashi, S, Ono, Y, Onishi, Y, Kanamori, H, Aotsuka, N, Ozawa, Y, Ogawa, H, Sakura, T, Ohashi, K, Ichinohe, T, Kato, K, Atsuta, Y, Teshima, T, Murata, M

    Published in Leukemia (01-03-2017)
    “…The effect of graft-versus-host disease (GVHD) on transplant outcomes after unrelated cord blood transplantation (UCBT) has not been fully elucidated. We…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Increase of bone marrow macrophages and CD8+ T lymphocytes predict graft failure after allogeneic bone marrow or cord blood transplantation by Kawashima, N, Terakura, S, Nishiwaki, S, Koyama, D, Ozawa, Y, Ito, M, Miyamura, K

    Published in Bone marrow transplantation (Basingstoke) (01-08-2017)
    “…Graft failure (GF) remains an obstacle to survival after allogeneic hematopoietic stem cell transplantation. However, differentiating GF from delayed…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Integration of humoral and cellular HLA-specific immune responses in cord blood allograft rejection by Hanajiri, R, Murata, M, Sugimoto, K, Murase, M, Sakemura, R, Goto, T, Watanabe, K, Imahashi, N, Terakura, S, Ohashi, H, Akatsuka, Y, Kurahashi, S, Miyamura, K, Kiyoi, H, Nishida, T, Naoe, T

    Published in Bone marrow transplantation (Basingstoke) (01-09-2015)
    “…In allo-stem cell transplantation (SCT), it is unclear whether donor-specific anti-HLA Abs (DSAs) can actually mediate graft rejection or if they are simply…”
    Get full text
    Journal Article
  8. 8

    Unrelated cord blood transplantation vs related transplantation with HLA 1-antigen mismatch in the graft-versus-host direction by Kanda, J, Ichinohe, T, Kato, S, Uchida, N, Terakura, S, Fukuda, T, Hidaka, M, Ueda, Y, Kondo, T, Taniguchi, S, Takahashi, S, Nagamura-Inoue, T, Tanaka, J, Atsuta, Y, Miyamura, K, Kanda, Y

    Published in Leukemia (01-02-2013)
    “…Little information is available regarding whether an unrelated cord blood (UCB) unit or a related donor with a 1-antigen mismatch at the HLA-A, HLA-B or HLA-DR…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Short-term methotrexate could reduce early immune reactions and improve outcomes in umbilical cord blood transplantation for adults by NARIMATSU, H, TERAKURA, S, SAWA, M, MIYAMURA, K, MORISHITA, Y, MATSUO, K, OBA, T, UCHIDA, T, IIDA, H, HAMAGUCHI, M, WATANABE, M, KOHNO, A, MURATA, M

    Published in Bone marrow transplantation (Basingstoke) (01-01-2007)
    “…Post transplant immune disorders are problematic in cord blood transplantation (CBT) for adult patients, and optimal prophylaxis has not been established. We…”
    Get full text
    Journal Article
  11. 11

    Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease by NISHIDA, T, HAMAGUCHI, M, SUZUKI, R, MORISHITA, Y, KODERA, Y, HIRABAYASHI, N, HANEDA, M, TERAKURA, S, ATSUTA, Y, IMAGAMA, S, KANIE, T, MURATA, M, TAJI, H

    Published in Bone marrow transplantation (Basingstoke) (01-06-2004)
    “…Thrombotic microangiopathy after bone marrow transplantation (post-BMT TMA) is a serious transplant-related complication. We identified 16 patients with TMA…”
    Get full text
    Journal Article
  12. 12

    Eosinophilia predicts better overall survival after acute graft-versus-host-disease by Imahashi, N, Miyamura, K, Seto, A, Watanabe, K, Yanagisawa, M, Nishiwaki, S, Shinba, M, Yasuda, T, Kuwatsuka, Y, Terakura, S, Kodera, Y

    Published in Bone marrow transplantation (Basingstoke) (01-02-2010)
    “…The prognostic significance of eosinophilia after allogeneic hematopoietic SCT (HSCT) and the relationship between eosinophilia and acute GVHD are not well…”
    Get full text
    Journal Article
  13. 13

    Donor single nucleotide polymorphism in the CCR9 gene affects the incidence of skin GVHD by Inamoto, Y, Murata, M, Katsumi, A, Kuwatsuka, Y, Tsujimura, A, Ishikawa, Y, Sugimoto, K, Onizuka, M, Terakura, S, Nishida, T, Kanie, T, Taji, H, Iida, H, Suzuki, R, Abe, A, Kiyoi, H, Matsushita, T, Miyamura, K, Kodera, Y, Naoe, T

    Published in Bone marrow transplantation (Basingstoke) (01-02-2010)
    “…The interactions between chemokines and their receptors may have an important role in initiating GVHD after allogeneic hematopoietic SCT (allo-HSCT). CCL25 and…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Increased risk for treatment-related mortality after bone marrow transplantation in GSTM1-positive recipients by TERAKURA, S, MURATA, M, NISHIDA, T, EMI, N, AKATSUKA, Y, MORISHIMA, Y, KODERA, Y, NAOE, T

    Published in Bone marrow transplantation (Basingstoke) (01-02-2006)
    “…Treatment-related mortality (TRM) is a major obstacle to successful allogeneic hematopoietic stem cell transplantation (HSCT). A variety of drugs are used in…”
    Get full text
    Journal Article
  16. 16

    Risk and prognostic factors for Japanese patients with chronic graft-versus-host disease after bone marrow transplantation by ATSUTA, Y, SUZUKI, R, HAMAGUCHI, M, KODERA, Y, SAO, H, MORISHIMA, Y, HAMAJIMA, N, MORISHITA, Y, YAMAMOTO, K, TERAKURA, S, IIDA, H, KOHNO, A, NAOE, T, YANO, K, WAKITA, A, TAJI, H

    Published in Bone marrow transplantation (Basingstoke) (01-02-2006)
    “…The incidence and prognostic factors for chronic graft-versus-host disease (cGVHD) were evaluated for 255 Japanese patients who survived more than 100 days…”
    Get full text
    Journal Article
  17. 17

    Busulfex (i.v. BU) and CY regimen before SCT: Japanese-targeted phase II pharmacokinetics combined study by Kim, S-W, Mori, S-i, Tanosaki, R, Fukuda, T, Kami, M, Sakamaki, H, Yamashita, T, Kodera, Y, Terakura, S, Taniguchi, S, Miyakoshi, S, Usui, N, Yano, S, Kawano, Y, Nagatoshi, Y, Harada, M, Morishima, Y, Okamoto, S, Saito, A M, Ohashi, Y, Ueda, R, Takaue, Y

    Published in Bone marrow transplantation (Basingstoke) (01-04-2009)
    “…To evaluate the toxicity and efficacy of an i.v. preparation of BU (12.8 mg/kg), combined with CY (120 mg/kg), a prospective study was performed on 30 Japanese…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Clinical characteristics of chronic graft-versus-host disease following umbilical cord blood transplantation for adults by Sugimoto, K, Narimatsu, H, Kawase, T, Iida, H, Watanabe, M, Kohno, A, Kuwatsuka, Y, Uchida, T, Hamaguchi, M, Terakura, S, Naoe, T, Matsuo, K, Murata, M, Sawa, M, Miyamura, K, Morishita, Y

    Published in Bone marrow transplantation (Basingstoke) (01-04-2008)
    “…Chronic GVHD is a significant complication following allogeneic hematopoietic stem cell transplantation; however, the clinical characteristics of chronic GVHD…”
    Get full text
    Journal Article
  20. 20

    Increased frequency of the angiotensin-converting enzyme gene D-allele is associated with noninfectious pulmonary dysfunction following allogeneic stem cell transplant by ONIZUKA, M, KASAI, M, OBA, T, ATSUTA, Y, TERAKURA, S, SUZUKI, R, KITAORI, K, MIYAMURA, K, HOTTA, T, KODERA, Y

    Published in Bone marrow transplantation (Basingstoke) (01-10-2005)
    “…Noninfectious pulmonary dysfunction (NIPD) is a common and often fatal complication associated with allogeneic hematopoietic stem cell transplantation (HSCT)…”
    Get full text
    Journal Article